{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T10:44:49Z","timestamp":1794307489465,"version":"4.9.0"},"reference-count":169,"publisher":"American Diabetes Association","issue":"Supplement_1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:p>The American Diabetes Association (ADA) \u201cStandards of Care in Diabetes\u201d includes the ADA\u2019s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee for Diabetes, an interprofessional expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA\u2019s clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org\/SOC.<\/jats:p>","DOI":"10.2337\/dc26-s012","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T14:53:08Z","timestamp":1765205588000},"page":"S261-S276","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":119,"title":["12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes\u20142026"],"prefix":"10.2337","volume":"49","author":[{"name":"American Diabetes Association Professional Practice Committee for Diabetes*","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7263-5425","authenticated-orcid":false,"given":"Mandeep","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2289-3183","authenticated-orcid":false,"given":"Rozalina G.","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5455-6037","authenticated-orcid":false,"given":"Kirthikaa","family":"Balapattabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8069-5783","authenticated-orcid":false,"given":"Raveendhara R.","family":"Bannuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4439-7374","authenticated-orcid":false,"given":"Natalie J.","family":"Bellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3376-8329","authenticated-orcid":false,"given":"Allison K.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6486-8234","authenticated-orcid":false,"given":"Elizabeth A.","family":"Beverly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2224-2548","authenticated-orcid":false,"given":"Kathaleen","family":"Briggs Early","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3893-8670","authenticated-orcid":false,"given":"Brian C.","family":"Callaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8487-5485","authenticated-orcid":false,"given":"Sathyavathi","family":"ChallaSivaKanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8460-1617","authenticated-orcid":false,"given":"Justin B.","family":"Echouffo-Tcheugui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6331-5224","authenticated-orcid":false,"given":"Brendan M.","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9095-303X","authenticated-orcid":false,"given":"Robert G.","family":"Frykberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7779-1619","authenticated-orcid":false,"given":"Rajesh","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9115-6080","authenticated-orcid":false,"given":"Sunir J.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9675-3001","authenticated-orcid":false,"given":"Lori M.","family":"Laffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8055-944X","authenticated-orcid":false,"given":"Rayhan","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Matfin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9388-9504","authenticated-orcid":false,"given":"Naushira","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6258-3975","authenticated-orcid":false,"given":"Elizabeth J.","family":"Pekas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0520-0776","authenticated-orcid":false,"given":"Anne L.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3292-9047","authenticated-orcid":false,"given":"Scott J.","family":"Pilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0572-7538","authenticated-orcid":false,"given":"Giulio R.","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9903-4002","authenticated-orcid":false,"given":"Sylvia E.","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4895-9598","authenticated-orcid":false,"given":"Alissa R.","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7399-3934","authenticated-orcid":false,"given":"Emily D.","family":"Szmuilowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1217-4916","authenticated-orcid":false,"given":"Nuha A.","family":"ElSayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"2026091111515655600_B1","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jama.2025.5956","article-title":"Diagnosis and treatment of type 2 diabetes in adults: a review","volume":"334","author":"Kalyani","year":"2025","journal-title":"JAMA"},{"key":"2026091111515655600_B2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2337\/dc24-2885","article-title":"The NIDDK takes on the complications of type 1 diabetes: the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) study","volume":"48","author":"Braffett","year":"2025","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B3","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.2337\/dc20-3097","article-title":"Understanding metabolic memory: the prolonged influence of glycemia during the Diabetes Control and Complications Trial (DCCT) on future risks of complications during the study of the Epidemiology of Diabetes Interventions and Complications (EDIC)","volume":"44","author":"Lachin","year":"2021","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-025-02175-1","article-title":"Diabetic neuropathy: cutting-edge research and future directions","volume":"10","author":"Yang","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"2026091111515655600_B5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2337\/dc16-2641","article-title":"Diabetic retinopathy: a position statement by the American Diabetes Association","volume":"40","author":"Solomon","year":"2017","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"2026091111515655600_B7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s001250051594","article-title":"UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis","volume":"44","author":"Stratton","year":"2001","journal-title":"Diabetologia"},{"key":"2026091111515655600_B8","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1053\/ajkd.1998.v31.pm9631838","article-title":"Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM","volume":"31","author":"Estacio","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"2026091111515655600_B9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1001288","article-title":"Effects of medical therapies on retinopathy progression in type 2 diabetes","volume":"363","author":"Chew","year":"2010","journal-title":"N Engl J Med"},{"key":"2026091111515655600_B11","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/CIRCULATIONAHA.113.002529","article-title":"Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries","volume":"129","author":"Sacks","year":"2014","journal-title":"Circulation"},{"key":"2026091111515655600_B12","doi-asserted-by":"crossref","first-page":"e19236","DOI":"10.1097\/MD.0000000000019236","article-title":"Prevalence and risk factors of diabetic retinopathy in diabetic patients: a community based cross-sectional study","volume":"99","author":"Yin","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"2026091111515655600_B13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"2026091111515655600_B14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jamaophthalmol.2015.4606","article-title":"Effects of prior intensive insulin therapy and risk factors on patient-reported visual function outcomes in the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) cohort","volume":"134","author":"Gubitosi-Klug","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"2026091111515655600_B15","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa1409463","article-title":"Intensive diabetes therapy and ocular surgery in type 1 diabetes","volume":"372","author":"Aiello","year":"2015","journal-title":"N Engl J Med"},{"key":"2026091111515655600_B16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/jamaophthalmol.2024.6058","article-title":"Ophthalmic complications associated with the antidiabetic drugs semaglutide and tirzepatide","volume":"143","author":"Katz","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"2026091111515655600_B17","doi-asserted-by":"crossref","first-page":"108255","DOI":"10.1016\/j.jdiacomp.2022.108255","article-title":"Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes\u2014a systematic review and meta-analysis","volume":"36","author":"Yoshida","year":"2022","journal-title":"J Diabetes Complications"},{"key":"2026091111515655600_B18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00417-023-06236-5","article-title":"Effects of newer-generation anti-diabetics on diabetic retinopathy: a critical review","volume":"262","author":"Ntentakis","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2026091111515655600_B19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2337\/dc20-1815","article-title":"HbA1c change and diabetic retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: a meta-analysis and meta-regression","volume":"44","author":"Bethel","year":"2021","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ajo.2025.05.007","article-title":"Association of glucagon-like peptide-1 receptor agonists with optic nerve and retinal adverse events: a population-based observational study across 180 countries","volume":"277","author":"Lakhani","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"2026091111515655600_B21","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamaophthalmol.2024.2296","article-title":"Risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide","volume":"142","author":"Hathaway","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"2026091111515655600_B22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/jamaophthalmol.2025.1455","article-title":"Glucagon-like peptide-1 receptor agonists and risk of neovascular age-related macular degeneration","volume":"143","author":"Shor","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"2026091111515655600_B23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ajo.2024.10.021","article-title":"Response to: \u201cComment on: association between glucagon-like peptide 1 receptor agonists exposure and intraocular pressure change","volume":"270","author":"Hallaj","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"2026091111515655600_B24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/bjophthalmol-2021-319232","article-title":"Glucagon-like peptide 1 receptor agonist use is associated with reduced risk for glaucoma","volume":"107","author":"Sterling","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"2026091111515655600_B25","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ophtha.2024.03.004","article-title":"Association between glucagon-like peptide-1 receptor agonists and the risk of glaucoma in individuals with type 2 diabetes","volume":"131","author":"Niazi","year":"2024","journal-title":"Ophthalmology"},{"key":"2026091111515655600_B26","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.2017.0686","article-title":"Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood","volume":"317","author":"Dabelea","year":"2017","journal-title":"JAMA"},{"key":"2026091111515655600_B27","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2337\/dc21-1072","article-title":"Development and progression of diabetic retinopathy in adolescents and young adults with type 2 diabetes: results from the TODAY study","volume":"45","author":"TODAY Study Group","year":"2021","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B28","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.2337\/dc22-2503","article-title":"Prevalence, progression, and modifiable risk factors for diabetic retinopathy in youth and young adults with youth-onset type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Study","volume":"46","author":"Jensen","year":"2023","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B29","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.2337\/dc10-2308","article-title":"Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy","volume":"34","author":"Agardh","year":"2011","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B30","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1612836","article-title":"Frequency of evidence-based screening for retinopathy in type 1 diabetes","volume":"376","author":"Nathan","year":"2017","journal-title":"N Engl J Med"},{"key":"2026091111515655600_B31","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.ophtha.2016.01.043","article-title":"Identification of diabetic retinopathy and ungradable image rate with ultrawide field imaging in a national teleophthalmology program","volume":"123","author":"Silva","year":"2016","journal-title":"Ophthalmology"},{"key":"2026091111515655600_B32","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/jamaophthalmol.2015.5083","article-title":"Evaluation of automated teleretinal screening program for diabetic retinopathy","volume":"134","author":"Walton","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"2026091111515655600_B33","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jamainternmed.2017.0204","article-title":"Implementation and evaluation of a large-scale teleretinal diabetic retinopathy screening program in the Los Angeles County Department of Health Services","volume":"177","author":"Daskivich","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2026091111515655600_B34","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/1932296816629983","article-title":"The evolution of teleophthalmology programs in the United Kingdom: beyond diabetic retinopathy screening","volume":"10","author":"Sim","year":"2016","journal-title":"J Diabetes Sci Technol"},{"key":"2026091111515655600_B35","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.2337\/dci23-0032","article-title":"Artificial intelligence and diabetic retinopathy: AI framework, prospective studies, head-to-head validation, and cost-effectiveness","volume":"46","author":"Rajesh","year":"2023","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B36","doi-asserted-by":"crossref","first-page":"2258149","DOI":"10.1080\/07853890.2023.2258149","article-title":"Artificial intelligence for telemedicine diabetic retinopathy screening: a review","volume":"55","author":"Nakayama","year":"2023","journal-title":"Ann Med"},{"key":"2026091111515655600_B37","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.2337\/db07-1024","article-title":"A 20-year prospective study of childbearing and incidence of diabetes in young women, controlling for glycemia before conception: the Coronary Artery Risk Development in Young Adults (CARDIA) study","volume":"56","author":"Gunderson","year":"2007","journal-title":"Diabetes"},{"key":"2026091111515655600_B38","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/jamaophthalmol.2022.0050","article-title":"Global estimates of diabetic retinopathy prevalence and progression in pregnant women with preexisting diabetes: a systematic review and meta-analysis","volume":"140","author":"Widyaputri","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"2026091111515655600_B39","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2337\/diacare.23.8.1084","article-title":"Effect of pregnancy on microvascular complications in the diabetes control and complications trial","volume":"23","author":"Diabetes Control and Complications Trial Research Group","year":"2000","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B40","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41433-023-02811-6","article-title":"Intravitreal anti-vascular endothelial growth factor injections in pregnancy and breastfeeding: a case series and systematic review of the literature","volume":"38","author":"Ong","year":"2024","journal-title":"Eye (Lond)"},{"key":"2026091111515655600_B41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0002-9394(76)90292-0","article-title":"Preliminary report on effects of photocoagulation therapy","volume":"81","author":"Diabetic Retinopathy Study Research Group","year":"1976","journal-title":"Am J Ophthalmol"},{"key":"2026091111515655600_B42","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1001\/archopht.1985.01050120030015","article-title":"Photocoagulation for diabetic macular edema","volume":"103","author":"Early Treatment Diabetic Retinopathy Study Research Group","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"2026091111515655600_B43","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/jama.2015.15217","article-title":"Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial","volume":"314","author":"Gross","year":"2015","journal-title":"JAMA"},{"key":"2026091111515655600_B44","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(17)31193-5","article-title":"Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial","volume":"389","author":"Sivaprasad","year":"2017","journal-title":"Lancet"},{"key":"2026091111515655600_B45","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ophtha.2018.07.027","article-title":"Outcomes of eyes lost to follow-up with proliferative diabetic retinopathy that received panretinal photocoagulation versus intravitreal anti-vascular endothelial growth factor","volume":"126","author":"Obeid","year":"2019","journal-title":"Ophthalmology"},{"key":"2026091111515655600_B46","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jamaophthalmol.2021.0606","article-title":"Effect of intravitreous anti-vascular endothelial growth factor vs sham treatment for prevention of vision-threatening complications of diabetic retinopathy: the Protocol W randomized clinical trial","volume":"139","author":"Maturi","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"2026091111515655600_B47","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ophtha.2010.12.033","article-title":"Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema","volume":"118","author":"Elman","year":"2011","journal-title":"Ophthalmology"},{"key":"2026091111515655600_B48","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ophtha.2011.01.031","article-title":"The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema","volume":"118","author":"Mitchell","year":"2011","journal-title":"Ophthalmology"},{"key":"2026091111515655600_B49","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","article-title":"Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema","volume":"372","author":"Wells","year":"2015","journal-title":"N Engl J Med"},{"key":"2026091111515655600_B50","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(22)00018-6","article-title":"Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials","volume":"399","author":"Wykoff","year":"2022","journal-title":"Lancet"},{"key":"2026091111515655600_B51","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(24)00063-1","article-title":"Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial","volume":"403","author":"Lanzetta","year":"2024","journal-title":"Lancet"},{"key":"2026091111515655600_B52","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.2019.5790","article-title":"Effect of initial management with aflibercept vs laser photocoagulation vs observation on vision loss among patients with diabetic macular edema involving the center of the macula and good visual acuity: a randomized clinical trial","volume":"321","author":"Baker","year":"2019","journal-title":"JAMA"},{"key":"2026091111515655600_B53","first-page":"CD005656","article-title":"Intravitreal steroids for macular edema in diabetes","volume":"11","author":"Rittiphairoj","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2026091111515655600_B54","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12886-022-02323-z","article-title":"Effect of anticoagulant\/antiplatelet therapy on the development and progression of diabetic retinopathy","volume":"22","author":"Jeng","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"2026091111515655600_B55","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.ophtha.2014.07.019","article-title":"The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study","volume":"121","author":"Chew","year":"2014","journal-title":"Ophthalmology"},{"key":"2026091111515655600_B56","first-page":"CD013318","article-title":"Fenofibrate for diabetic retinopathy","volume":"6","author":"Kataoka","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"2026091111515655600_B57","doi-asserted-by":"crossref","first-page":"EVIDoa2400179","DOI":"10.1056\/EVIDoa2400179","article-title":"Effect of fenofibrate on progression of diabetic retinopathy","volume":"3","author":"Preiss","year":"2024","journal-title":"NEJM Evid"},{"key":"2026091111515655600_B58","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.tcm.2022.11.003","article-title":"The role of statins in diabetic retinopathy","volume":"34","author":"Tomkins-Netzer","year":"2024","journal-title":"Trends Cardiovasc Med"},{"key":"2026091111515655600_B59","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.oret.2024.12.006","article-title":"Influence of common medications on diabetic macular edema in type 2 diabetes mellitus","volume":"9","author":"Muayad","year":"2025","journal-title":"Ophthalmol Retina"},{"key":"2026091111515655600_B60","unstructured":"Centers for Disease Control and Prevention\n          . National Diabetes Statistics Report: Coexisting Conditions and Complications, 2024. Accessed 2 August 2025. Available from https:\/\/www.cdc.gov\/diabetes\/php\/data-research\/index.html"},{"key":"2026091111515655600_B61","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamaophthalmol.2016.2213","article-title":"Association between diabetes-related eye complications and symptoms of anxiety and depression","volume":"134","author":"Rees","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"2026091111515655600_B62","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev-med-043021-033114","article-title":"Spectrum of diabetic neuropathy: new insights in diagnosis and treatment","volume":"75","author":"Dillon","year":"2024","journal-title":"Annu Rev Med"},{"key":"2026091111515655600_B63","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B64","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.2337\/dc11-0156","article-title":"The Ipswich Touch Test: a simple and novel method to identify inpatients with diabetes at risk of foot ulceration","volume":"34","author":"Rayman","year":"2011","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B65","doi-asserted-by":"crossref","first-page":"e046966","DOI":"10.1136\/bmjopen-2020-046966","article-title":"Application of the Ipswich Touch Test for diabetic peripheral neuropathy screening: a systematic review and meta-analysis","volume":"11","author":"Zhao","year":"2021","journal-title":"BMJ Open"},{"key":"2026091111515655600_B66","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/mus.24628","article-title":"AANEM\u2019s top five choosing wisely recommendations","volume":"51","author":"AANEM","year":"2015","journal-title":"Muscle Nerve"},{"key":"2026091111515655600_B67","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11892-009-0069-7","article-title":"Not all neuropathy in diabetes is of diabetic etiology: differential diagnosis of diabetic neuropathy","volume":"9","author":"Freeman","year":"2009","journal-title":"Curr Diab Rep"},{"key":"2026091111515655600_B68","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jacc.2012.10.028","article-title":"Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT\/EDIC study (Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications)","volume":"61","author":"Pop-Busui","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026091111515655600_B69","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.2337\/dc10-0125","article-title":"Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial","volume":"33","author":"Pop-Busui","year":"2010","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B70","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00125-025-06365-y","article-title":"Diabetic gastroenteropathy: a pan-alimentary complication","volume":"68","author":"Kornum","year":"2025","journal-title":"Diabetologia"},{"key":"2026091111515655600_B71","doi-asserted-by":"crossref","first-page":"e14644","DOI":"10.1111\/dme.14644","article-title":"Sexual health and function in women with diabetes","volume":"38","author":"Winkley","year":"2021","journal-title":"Diabet Med"},{"key":"2026091111515655600_B72","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s11892-014-0528-7","article-title":"Glucose control and diabetic neuropathy: lessons from recent large clinical trials","volume":"14","author":"Ang","year":"2014","journal-title":"Curr Diab Rep"},{"key":"2026091111515655600_B73","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2337\/dc13-2114","article-title":"Neuropathy and related findings in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study","volume":"37","author":"Martin","year":"2014","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B74","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","article-title":"Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial","volume":"376","author":"Ismail-Beigi","year":"2010","journal-title":"Lancet"},{"key":"2026091111515655600_B75","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00125-017-4253-z","article-title":"Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study","volume":"60","author":"Look AHEAD Research Group","year":"2017","journal-title":"Diabetologia"},{"key":"2026091111515655600_B76","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/oby.23246","article-title":"Dietary weight loss in people with severe obesity stabilizes neuropathy and improves symptomatology","volume":"29","author":"Callaghan","year":"2021","journal-title":"Obesity (Silver Spring)"},{"key":"2026091111515655600_B77","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1007\/s11695-019-04004-1","article-title":"The effect of bariatric surgery on peripheral polyneuropathy: a systematic review and meta-analysis","volume":"29","author":"Aghili","year":"2019","journal-title":"Obes Surg"},{"key":"2026091111515655600_B78","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1007\/s00125-023-05899-3","article-title":"The effect of surgical weight loss on diabetes complications in individuals with class II\/III obesity","volume":"66","author":"Reynolds","year":"2023","journal-title":"Diabetologia"},{"key":"2026091111515655600_B79","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ana.410380607","article-title":"Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial","volume":"38","author":"Diabetes Control and Complications Trial (DCCT) Research Group","year":"1995","journal-title":"Ann Neurol"},{"key":"2026091111515655600_B80","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s001250050924","article-title":"The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT)","volume":"41","author":"Diabetes Control and Complications Trial (DCCT) Research Group","year":"1998","journal-title":"Diabetologia"},{"key":"2026091111515655600_B81","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/dc09-1941","article-title":"Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) study","volume":"33","author":"Albers","year":"2010","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B82","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/CIRCULATIONAHA.108.837369","article-title":"Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications study (DCCT\/EDIC)","volume":"119","author":"Pop-Busui","year":"2009","journal-title":"Circulation"},{"key":"2026091111515655600_B83","first-page":"CD007543","article-title":"Enhanced glucose control for preventing and treating diabetic neuropathy","volume":"2012","author":"Callaghan","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2026091111515655600_B84","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.2337\/dc13-0012","article-title":"Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) cohort","volume":"36","author":"Pop-Busui","year":"2013","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B85","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2337\/dc20-1842","article-title":"Intensive risk factor management and cardiovascular autonomic neuropathy in type 2 diabetes: the ACCORD trial","volume":"44","author":"Tang","year":"2021","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B86","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/WCO.0000000000001292","article-title":"Obesity-related neuropathy: the new epidemic","volume":"37","author":"Elafros","year":"2024","journal-title":"Curr Opin Neurol"},{"key":"2026091111515655600_B87","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1007\/s00125-023-05988-3","article-title":"Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy","volume":"66","author":"Goldney","year":"2023","journal-title":"Diabetologia"},{"key":"2026091111515655600_B88","doi-asserted-by":"crossref","first-page":"1268619","DOI":"10.3389\/fendo.2023.1268619","article-title":"Glucagon-like peptide-1 receptor agonists for the management of diabetic peripheral neuropathy","volume":"14","author":"Liu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026091111515655600_B89","first-page":"935","article-title":"Once-weekly semaglutide 7\u00b72 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial","volume":"13","author":"Lingvay"},{"key":"2026091111515655600_B90","doi-asserted-by":"crossref","first-page":"1463657","DOI":"10.3389\/fphar.2024.1463657","article-title":"Analysis of tirzepatide in the US FDA adverse event reporting system (FAERS): a focus on overall patient population and sex-specific subgroups","volume":"15","author":"Ou","year":"2024","journal-title":"Front Pharmacol"},{"key":"2026091111515655600_B91","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1080\/09593985.2023.2227975","article-title":"Effects of exercise therapy on diabetic neuropathy: a systematic review and meta-analysis","volume":"40","author":"Hernando-Garijo","year":"2024","journal-title":"Physiother Theory Pract"},{"key":"2026091111515655600_B92","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s40279-021-01596-6","article-title":"Exercise and neuropathy: systematic review with meta-analysis","volume":"52","author":"Streckmann","year":"2022","journal-title":"Sports Med"},{"key":"2026091111515655600_B93","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/dc16-0081","article-title":"Metabolic syndrome components are associated with symptomatic polyneuropathy independent of glycemic status","volume":"39","author":"Callaghan","year":"2016","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B94","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41598-020-79276-0","article-title":"A systematic review and meta-analysis of the serum lipid profile in prediction of diabetic neuropathy","volume":"11","author":"Cai","year":"2021","journal-title":"Sci Rep"},{"key":"2026091111515655600_B95","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/acn3.51639","article-title":"Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes","volume":"9","author":"Afshinnia","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"2026091111515655600_B96","doi-asserted-by":"crossref","first-page":"534372","DOI":"10.3389\/fpubh.2020.534372","article-title":"Prevalence and risk factors for diabetic peripheral neuropathy in type 2 diabetic patients from 14 countries: estimates of the INTERPRET-DD study","volume":"8","author":"Lu","year":"2020","journal-title":"Front Public Health"},{"key":"2026091111515655600_B97","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/j.pain.0000000000001744","article-title":"Diabetic polyneuropathy and pain, prevalence, and patient characteristics: a cross-sectional questionnaire study of 5,514 patients with recently diagnosed type 2 diabetes","volume":"161","author":"Gylfadottir","year":"2020","journal-title":"Pain"},{"key":"2026091111515655600_B98","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1212\/WNL.0000000000003882","article-title":"Pharmacotherapy for diabetic peripheral neuropathy pain and quality of life: a systematic review","volume":"88","author":"Waldfogel","year":"2017","journal-title":"Neurology"},{"key":"2026091111515655600_B99","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1212\/WNL.0000000000013038","article-title":"Oral and topical treatment of painful diabetic polyneuropathy: practice guideline update summary: report of the AAN Guideline Subcommittee","volume":"98","author":"Price","year":"2022","journal-title":"Neurology"},{"key":"2026091111515655600_B100","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2147\/JPR.S442595","article-title":"Update on treating painful diabetic peripheral neuropathy: a review of current US guidelines with a focus on the most recently approved management options","volume":"17","author":"Mallick-Searle","year":"2024","journal-title":"J Pain Res"},{"key":"2026091111515655600_B101","doi-asserted-by":"crossref","DOI":"10.2337\/db2022-01","volume-title":"Diagnosis and Treatment of Painful Diabetic Peripheral Neuropathy.","author":"Pop-Busui","year":"2022"},{"key":"2026091111515655600_B102","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0140-6736(22)01472-6","article-title":"Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial","volume":"400","author":"Tesfaye","year":"2022","journal-title":"Lancet"},{"key":"2026091111515655600_B103","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2337\/dc07-2105","article-title":"Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses","volume":"31","author":"Freeman","year":"2008","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B104","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jpain.2006.06.005","article-title":"Symptom profiles differ in patients with neuropathic versus non-neuropathic pain","volume":"8","author":"Dworkin","year":"2007","journal-title":"J Pain"},{"key":"2026091111515655600_B105","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2217\/pmt-2023-0006","article-title":"Topical capsaicin for the management of painful diabetic neuropathy: a narrative systematic review","volume":"13","author":"Goodwin","year":"2023","journal-title":"Pain Manag"},{"key":"2026091111515655600_B106","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.0b013e3182166ebe","article-title":"Evidence-based guideline: treatment of painful diabetic neuropathy [RETIRED]","volume":"76","author":"Bril","year":"2011","journal-title":"Neurology"},{"key":"2026091111515655600_B107","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2013United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"2026091111515655600_B108","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1212\/WNL.0000000000000839","article-title":"Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology","volume":"83","author":"Franklin","year":"2014","journal-title":"Neurology"},{"key":"2026091111515655600_B109","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.2019.1347","article-title":"Association of tramadol with all-cause mortality among patients with osteoarthritis","volume":"321","author":"Zeng","year":"2019","journal-title":"JAMA"},{"key":"2026091111515655600_B110","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/jch.12258","article-title":"Orthostatic hypotension associated with baroreceptor dysfunction: treatment approaches","volume":"16","author":"Briasoulis","year":"2014","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2026091111515655600_B111","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3949\/ccjm.77a.09118","article-title":"Preventing and treating orthostatic hypotension: as easy as A, B, C","volume":"77","author":"Figueroa","year":"2010","journal-title":"Cleve Clin J Med"},{"key":"2026091111515655600_B112","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/HJH.0000000000002078","article-title":"Management of supine hypertension in patients with neurogenic orthostatic hypotension: scientific statement of the American Autonomic Society, European Federation of Autonomic Societies, and the European Society of Hypertension","volume":"37","author":"Jordan","year":"2019","journal-title":"J Hypertens"},{"key":"2026091111515655600_B113","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.14309\/ajg.0000000000001874","article-title":"ACG clinical guideline: gastroparesis","volume":"117","author":"Camilleri","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"2026091111515655600_B114","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2337\/diaspect.20.4.231","article-title":"Nutritional management of gastroparesis in people with diabetes","volume":"20","author":"Parrish","year":"2007","journal-title":"Diabetes Spectrum"},{"key":"2026091111515655600_B115","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/j.gastro.2011.04.045","article-title":"Dietary intake and nutritional deficiencies in patients with diabetic or idiopathic gastroparesis","volume":"141","author":"Parkman","year":"2011","journal-title":"Gastroenterology"},{"key":"2026091111515655600_B116","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ajg.2013.453","article-title":"A small particle size diet reduces upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trial","volume":"109","author":"Olausson","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"2026091111515655600_B117","volume-title":"2024-25 Guide to Medications for the Treatment of Diabetes","author":"White"},{"key":"2026091111515655600_B118","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.18295\/squmj.2019.19.04.004","article-title":"Pharmacological approaches to diabetic gastroparesis: a systematic review of randomised clinical trials","volume":"19","author":"Asha","year":"2019","journal-title":"Sultan Qaboos Univ Med J"},{"key":"2026091111515655600_B119","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cgh.2010.05.020","article-title":"Gastric electrical stimulation with Enterra therapy improves symptoms from diabetic gastroparesis in a prospective study","volume":"8","author":"McCallum","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026091111515655600_B120","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1067-2516(07)60001-5","article-title":"Diabetic foot disorders. A clinical practice guideline (2006 revision)","volume":"45","author":"Frykberg","year":"2006","journal-title":"J Foot Ankle Surg"},{"key":"2026091111515655600_B121","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2337\/dci22-0043","article-title":"Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers","volume":"46","author":"McDermott","year":"2023","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B122","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.2337\/dc08-9021","article-title":"Comprehensive foot examination and risk assessment","volume":"31","author":"Boulton","year":"2008","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B123","doi-asserted-by":"crossref","first-page":"e3657","DOI":"10.1002\/dmrr.3657","article-title":"Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update)","volume":"40","author":"Schaper","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"2026091111515655600_B124","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2337\/diacare.22.1.157","article-title":"Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings","volume":"22","author":"Reiber","year":"1999","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B125","doi-asserted-by":"crossref","first-page":"e3686","DOI":"10.1002\/dmrr.3686","article-title":"The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes and a foot ulcer","volume":"40","author":"Fitridge","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"2026091111515655600_B126","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"58","author":"Conte","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2026091111515655600_B127","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.2337\/diacare.26.12.3333","article-title":"Peripheral arterial disease in people with diabetes","volume":"26","author":"American Diabetes Association","year":"2003","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B128","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jvs.2013.08.003","article-title":"The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI)","volume":"59","author":"Mills","year":"2014","journal-title":"J Vasc Surg"},{"key":"2026091111515655600_B129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2023.10578","article-title":"Diabetic foot ulcers: a review","volume":"330","author":"Armstrong","year":"2023","journal-title":"JAMA"},{"key":"2026091111515655600_B130","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jvs.2017.12.079","article-title":"The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification independently predicts wound healing in diabetic foot ulcers","volume":"68","author":"Hicks","year":"2018","journal-title":"J Vasc Surg"},{"key":"2026091111515655600_B131","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/aphw.12314","article-title":"Information about foot care provided to people with diabetes with or without their partners: impact on recommended foot care behavior","volume":"14","author":"Reaney","year":"2022","journal-title":"Appl Psychol Health Well Being"},{"key":"2026091111515655600_B132","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1111\/iwj.13450","article-title":"A collaborative approach in patient education for diabetes foot and wound care: a pragmatic randomised controlled trial","volume":"17","author":"Heng","year":"2020","journal-title":"Int Wound J"},{"key":"2026091111515655600_B133","doi-asserted-by":"crossref","first-page":"e3651","DOI":"10.1002\/dmrr.3651","article-title":"Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update)","volume":"40","author":"Bus","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"2026091111515655600_B134","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejvs.2020.03.053","article-title":"A systematic review of the impact of foot care education on self efficacy and self care in patients with diabetes","volume":"60","author":"Goodall","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2026091111515655600_B135","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s12020-018-1821-z","article-title":"Correction to: people with diabetes do not learn and recall their diabetes foot education: a cohort study","volume":"63","author":"Yuncken","year":"2019","journal-title":"Endocrine"},{"key":"2026091111515655600_B136","doi-asserted-by":"crossref","first-page":"598","DOI":"10.12968\/jowc.2021.30.8.598","article-title":"People living with diabetes are unaware of their foot risk status or why they are referred to a multidisciplinary foot team","volume":"30","author":"Walton","year":"2021","journal-title":"J Wound Care"},{"key":"2026091111515655600_B137","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2337\/dc16-2294","article-title":"Feasibility and efficacy of a smart mat technology to predict development of diabetic plantar ulcers","volume":"40","author":"Frykberg","year":"2017","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B138","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3390\/medicina57040377","article-title":"Harnessing digital health technologies to remotely manage diabetic foot syndrome: a narrative review","volume":"57","author":"Najafi","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"2026091111515655600_B139","doi-asserted-by":"crossref","first-page":"e3251","DOI":"10.1002\/dmrr.3251","article-title":"Surgery for the diabetic foot: a key component of care","volume":"36","author":"Frykberg","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"2026091111515655600_B140","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2337\/dc11-0844","article-title":"The Charcot foot in diabetes","volume":"34","author":"Rogers","year":"2011","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B141","doi-asserted-by":"crossref","first-page":"e3653","DOI":"10.1002\/dmrr.3653","article-title":"Diagnosis and treatment of active Charcot neuro-osteoarthropathy in persons with diabetes mellitus: a systematic review","volume":"40","author":"Raspovic","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"2026091111515655600_B142","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5435\/JAAOS-D-22-00365","article-title":"The modern treatment of Charcot foot arthropathy","volume":"31","author":"Pinzur","year":"2023","journal-title":"J Am Acad Orthop Surg"},{"key":"2026091111515655600_B143","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jcot.2020.03.025","article-title":"Charcot foot reconstruction outcomes: a systematic review","volume":"11","author":"Ha","year":"2020","journal-title":"J Clin Orthop Trauma"},{"key":"2026091111515655600_B144","doi-asserted-by":"crossref","first-page":"112156","DOI":"10.1016\/j.diabres.2025.112156","article-title":"Impact of diabetes on long-term mortality following major lower limb amputation: a population-based cohort study in Wales","volume":"223","author":"Hayes","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"2026091111515655600_B145","first-page":"dc250292","article-title":"Differential effect of GLP-1 receptor agonists and SGLT2 inhibitors on lower-extremity amputation outcomes in type 2 diabetes: a nationwide retrospective cohort study","author":"Hong","year":"2025","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B146","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa2501006","article-title":"Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes","volume":"392","author":"McGuire","year":"2025","journal-title":"N Engl J Med"},{"key":"2026091111515655600_B147","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2337\/dc25-1082","article-title":"Benefit of semaglutide in symptomatic peripheral artery disease by baseline type 2 diabetes characteristics: insights from STRIDE, a randomized, placebo-controlled, double-blind trial","volume":"48","author":"Rasouli","year":"2025","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B148","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"2026091111515655600_B149","doi-asserted-by":"crossref","first-page":"e3687","DOI":"10.1002\/dmrr.3687","article-title":"IWGDF\/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF\/IDSA 2023)","volume":"40","author":"Senneville","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"2026091111515655600_B150","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/wound.2015.0635","article-title":"Challenges in the treatment of chronic wounds","volume":"4","author":"Frykberg","year":"2015","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"2026091111515655600_B151","doi-asserted-by":"crossref","first-page":"616","DOI":"10.2337\/dc19-0476","article-title":"A multinational, multicenter, randomized, double-blinded, placebo-controlled trial to evaluate the efficacy of cyclical topical wound oxygen (TWO2) therapy in the treatment of chronic diabetic foot ulcers: the TWO2 study","volume":"43","author":"Frykberg","year":"2020","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B152","doi-asserted-by":"crossref","DOI":"10.2337\/db2022-02","volume-title":"New Evidence-Based Therapies for Complex Diabetic Foot Wounds.","author":"Boulton","year":"2022"},{"key":"2026091111515655600_B153","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/wound.2022.0041","article-title":"Efficacy of topical wound oxygen therapy in healing chronic diabetic foot ulcers: systematic review and meta-analysis","volume":"12","author":"Carter","year":"2023","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"2026091111515655600_B154","doi-asserted-by":"crossref","first-page":"e3647","DOI":"10.1002\/dmrr.3647","article-title":"Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2023 update)","volume":"40","author":"Bus","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"2026091111515655600_B155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/1534734619888361","article-title":"Surgical offloading techniques should be used more often and earlier in treating forefoot diabetic ulcers: an evidence-based review","volume":"19","author":"Yammine","year":"2020","journal-title":"Int J Low Extrem Wounds"},{"key":"2026091111515655600_B156","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/1534734614555002","article-title":"The role of surgical off-loading to prevent recurrent ulcerations","volume":"13","author":"La Fontaine","year":"2014","journal-title":"Int J Low Extrem Wounds"},{"key":"2026091111515655600_B157","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2337\/diacare.26.6.1879","article-title":"Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial","volume":"26","author":"Sheehan","year":"2003","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B158","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00592-024-02320-2","article-title":"Effectiveness of different advanced wound dressings versus standard of care for the management of diabetic foot ulcers: a meta-analysis of randomized controlled trials for the development of the Italian guidelines for the treatment of diabetic foot syndrome","volume":"61","author":"Monami","year":"2024","journal-title":"Acta Diabetol"},{"key":"2026091111515655600_B159","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2337\/dc07-2196","article-title":"Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial","volume":"31","author":"Blume","year":"2008","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B160","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2337\/dc09-1754","article-title":"Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes","volume":"33","author":"L\u00f6ndahl","year":"2010","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B161","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2337\/dc17-0654","article-title":"Hyperbaric oxygen therapy in the treatment of ischemic lower-extremity ulcers in patients with diabetes: results of the DAMO2CLES multicenter randomized clinical trial","volume":"41","author":"Santema","year":"2018","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B162","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2337\/dc15-2001","article-title":"Hyperbaric oxygen therapy does not reduce indications for amputation in patients with diabetes with nonhealing ulcers of the lower limb: a prospective, double-blind, randomized controlled clinical trial","volume":"39","author":"Fedorko","year":"2016","journal-title":"Diabetes Care"},{"key":"2026091111515655600_B163","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/wrr.12776","article-title":"Hyperbaric oxygen therapy for nonischemic diabetic ulcers: a systematic review","volume":"28","author":"Lalieu","year":"2020","journal-title":"Wound Repair Regen"},{"key":"2026091111515655600_B164","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.12968\/jowc.2018.27.Sup9.S30","article-title":"Continuous diffusion of oxygen improves diabetic foot ulcer healing when compared with a placebo control: a randomised, double-blind, multicentre study","volume":"27","author":"Niederauer","year":"2018","journal-title":"J Wound Care"},{"key":"2026091111515655600_B165","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.12968\/jowc.2021.30.Sup5.S7","article-title":"Topical oxygen therapy in the treatment of diabetic foot ulcers: a multicentre, open, randomised controlled clinical trial","volume":"30","author":"Serena","year":"2021","journal-title":"J Wound Care"},{"key":"2026091111515655600_B166","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/iwj.13830","article-title":"Efficacy and safety of topical oxygen therapy for diabetic foot ulcers: an updated systematic review and meta-analysis","volume":"19","author":"Sun","year":"2022","journal-title":"Int Wound J"},{"key":"2026091111515655600_B167","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3390\/medicina57090917","article-title":"Topical wound oxygen therapy in the treatment of chronic diabetic foot ulcers","volume":"57","author":"Frykberg","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"2026091111515655600_B168","doi-asserted-by":"crossref","first-page":"100028","DOI":"10.1016\/j.hsr.2022.100028","article-title":"Topical oxygen therapy for healing diabetic foot ulcers: a systematic review and meta-analysis of randomised control trials","volume":"3","author":"Sethi","year":"2022","journal-title":"Health Sciences Review"},{"key":"2026091111515655600_B169","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.2337\/dc22-1111","article-title":"The at-risk diabetic foot: time to focus on prevention","volume":"45","author":"Frykberg","year":"2022","journal-title":"Diabetes Care"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/Supplement_1\/S261\/848830\/dc26s012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/Supplement_1\/S261\/848830\/dc26s012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:52:47Z","timestamp":1789141967000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/49\/Supplement_1\/S261\/163919\/12-Retinopathy-Neuropathy-and-Foot-Care-Standards"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":169,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2025,12,8]]},"published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc26-s012","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]}}}